Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 5-year Natural History Study in LAMA2-related Muscular Dystrophy and SELENON-related Myopathy: the Extended LAST STRONG Study

NCT06132750 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT06132750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06132750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 5-year Natural History Study in LAMA2-related Muscular Dystrophy and SELENON-related Myopathy: the Extended LAST STRONG Study
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Recruiting
Start date
October 6, 2023
Completion date
September 1, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lama2-related muscular dystrophy, selenon-related myopathy